Target Name: TJAP1
NCBI ID: G93643
Other Name(s): protein incorporated later into tight junctions | OTTHUMP00000224080 | OTTHUMP00000016456 | Protein incorporated later into tight junctions | TJAP1_HUMAN | Tight junction associated protein 1, transcript variant 1 | tight junction protein 4 (peripheral) | TJAP1 variant 1 | Tight junction-associated protein 1 (isoform a) | tight junction associated protein 1 | OTTHUMP00000016454 | Tight junction-associated protein 1 | OTTHUMP00000016453 | Tight junction protein 4 (peripheral) | OTTHUMP00000016455 | DKFZp686F06131 | tight junction associated protein 1 (peripheral) | TJP4 | Tight junction protein 4 | PILT

TJAP1: A Promising Drug Target and Biomarker for Tight Junction Analysis

Tight junctions are essential for maintaining tissue structure and function in various organisms, including humans. They are the primary barrier between epithelial cells, which forms the lining of various body surfaces and organs, and the surrounding tissue, ensuring the exchange of nutrients, waste products, and other substances. Tight junctions also play a crucial role in modulating the permeability of cell membranes, which is critical for the exchange of sensory information, as well as the regulation of ion and solute transport.

The regulation of tight junctions is a complex process that involves multiple signaling pathways. One of the key proteins involved in this regulation is TJAP1, which is a member of the tight junction protein family. TJAP1 is expressed in various tissues and organs and has been implicated in the development and maintenance of tight junctions in various organisms, including humans.

TJAP1: Structure and Function

TJAP1 is a 21-kDa protein that is expressed in various tissues, including the skin, heart, liver, and brain. It is primarily localized to the endoplasmic reticulum and can also be found in the cytoplasm. TJAP1 has a unique structure that consists of a catalytic domain, a transmembrane region, and an N-terminus.

The catalytic domain is the region of the protein that contains the known active sites for protein-protein interactions, which are crucial for the regulation of tight junctions. The transmembrane region is responsible for the formation of the tight junction and can also participate in the regulation of ion and solute transport. The N-terminus is the region that interacts with the cytoplasm and is involved in the regulation of tight junction formation and maintenance.

TJAP1 has been shown to play a critical role in the regulation of tight junctions in various organisms. For example, studies have shown that TJAP1 is involved in the regulation of tight junction formation in various tissues, including the skin and the heart. TJAP1 has also been shown to play a role in the regulation of ion and solute transport, which is critical for maintaining the integrity of tight junctions.

Drug Targeting and Biomarker

TJAP1 is a drug target of great interest due to its involvement in the regulation of tight junctions. Drugs that can modulate TJAP1 activity have the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the most promising drug targets for TJAP1 is the inhibition of its catalytic activity. This can be achieved through the use of small molecules, such as inhibitors of ATP-binding sites, which can inhibit the formation of the protein-protein interaction that is responsible for tight junction formation.

Another approach to targeting TJAP1 is the use of antibodies that recognize and specifically target the protein. This approach can be used to detect TJAP1 expression in various tissues and to monitor the effectiveness of drugs that target TJAP1.

TJAP1 has also been used as a biomarker for various diseases, including cancer. The expression of TJAP1 has been shown to be elevated in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that TJAP1 may be a useful biomarker for the diagnosis and prognosis of cancer.

Conclusion

TJAP1 is a protein that plays a critical role in the regulation of tight junctions in various organisms, including humans. Its regulation of tight junctions is involved in the maintenance of tissue structure and function, as well as the regulation of ion and solute transport. The inhibition of TJAP1 activity has the potential to treat various diseases, including cancer and neurodegenerative diseases.

Furthermore, TJAP1 has also been used as a biomarker for the diagnosis and prognosis of various diseases. The expression of TJAP1 has been shown to be elevated in

Protein Name: Tight Junction Associated Protein 1

Functions: Plays a role in regulating the structure of the Golgi apparatus

More Common Targets

TJP1 | TJP2 | TJP3 | TK1 | TK2 | TKFC | TKT | TKTL1 | TKTL2 | TLCD1 | TLCD2 | TLCD3A | TLCD3B | TLCD4 | TLCD4-RWDD3 | TLCD5 | TLDC2 | TLE1 | TLE1-DT | TLE2 | TLE3 | TLE4 | TLE5 | TLE6 | TLK1 | TLK2 | TLL1 | TLL2 | TLN1 | TLN2 | TLNRD1 | TLR1 | TLR10 | TLR12P | TLR2 | TLR3 | TLR4 | TLR5 | TLR6 | TLR7 | TLR8 | TLR8-AS1 | TLR9 | TLX1 | TLX1NB | TLX2 | TLX3 | TM2D1 | TM2D2 | TM2D3 | TM4SF1 | TM4SF1-AS1 | TM4SF18 | TM4SF19 | TM4SF19-AS1 | TM4SF19-DYNLT2B | TM4SF20 | TM4SF4 | TM4SF5 | TM6SF1 | TM6SF2 | TM7SF2 | TM7SF3 | TM9SF1 | TM9SF2 | TM9SF3 | TM9SF4 | TMA16 | TMA7 | TMBIM1 | TMBIM4 | TMBIM6 | TMC1 | TMC2 | TMC3 | TMC4 | TMC5 | TMC6 | TMC7 | TMC8 | TMCC1 | TMCC1-DT | TMCC2 | TMCC3 | TMCO1 | TMCO1-AS1 | TMCO2 | TMCO3 | TMCO4 | TMCO5A | TMCO5B | TMCO6 | TMED1 | TMED10 | TMED10P1 | TMED11P | TMED2 | TMED3 | TMED4 | TMED5